187 related articles for article (PubMed ID: 8682513)
21. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds.
Tavtigian SV; Simard J; Rommens J; Couch F; Shattuck-Eidens D; Neuhausen S; Merajver S; Thorlacius S; Offit K; Stoppa-Lyonnet D; Belanger C; Bell R; Berry S; Bogden R; Chen Q; Davis T; Dumont M; Frye C; Hattier T; Jammulapati S; Janecki T; Jiang P; Kehrer R; Leblanc JF; Mitchell JT; McArthur-Morrison J; Nguyen K; Peng Y; Samson C; Schroeder M; Snyder SC; Steele L; Stringfellow M; Stroup C; Swedlund B; Swense J; Teng D; Thomas A; Tran T; Tranchant M; Weaver-Feldhaus J; Wong AK; Shizuya H; Eyfjord JE; Cannon-Albright L; Tranchant M; Labrie F; Skolnick MH; Weber B; Kamb A; Goldgar DE
Nat Genet; 1996 Mar; 12(3):333-7. PubMed ID: 8589730
[TBL] [Abstract][Full Text] [Related]
22. Allelic loss of the BRCA1 and BRCA2 genes and other regions on 17q and 13q in breast cancer among women from Taiwan (area of low incidence but early onset).
Lo YL; Yu JC; Huang CS; Tseng SL; Chang TM; Chang KJ; Wu CW; Shen CY
Int J Cancer; 1998 Dec; 79(6):580-7. PubMed ID: 9842965
[TBL] [Abstract][Full Text] [Related]
23. The genetics of inherited breast cancer.
Gayther SA; Pharoah PD; Ponder BA
J Mammary Gland Biol Neoplasia; 1998 Oct; 3(4):365-76. PubMed ID: 10819531
[TBL] [Abstract][Full Text] [Related]
24. Loss of heterozygosity in sporadic breast tumours at the BRCA2 locus on chromosome 13q12-q13.
Cleton-Jansen AM; Collins N; Lakhani SR; Weissenbach J; Devilee P; Cornelisse CJ; Stratton MR
Br J Cancer; 1995 Nov; 72(5):1241-4. PubMed ID: 7577475
[TBL] [Abstract][Full Text] [Related]
25. Patterns of loss of heterozygosity at loci from chromosome arm 13q suggests a possible involvement of BRCA2 in sporadic breast tumors.
Kerangueven F; Allione F; Noguchi T; Adélaïde J; Sobol H; Jacquemier J; Birnbaum D
Genes Chromosomes Cancer; 1995 Aug; 13(4):291-4. PubMed ID: 7547638
[TBL] [Abstract][Full Text] [Related]
26. Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13.
Easton DF; Steele L; Fields P; Ormiston W; Averill D; Daly PA; McManus R; Neuhausen SL; Ford D; Wooster R; Cannon-Albright LA; Stratton MR; Goldgar DE
Am J Hum Genet; 1997 Jul; 61(1):120-8. PubMed ID: 9245992
[TBL] [Abstract][Full Text] [Related]
27. BRCA2 germline mutations in male breast cancer cases and breast cancer families.
Couch FJ; Farid LM; DeShano ML; Tavtigian SV; Calzone K; Campeau L; Peng Y; Bogden B; Chen Q; Neuhausen S; Shattuck-Eidens D; Godwin AK; Daly M; Radford DM; Sedlacek S; Rommens J; Simard J; Garber J; Merajver S; Weber BL
Nat Genet; 1996 May; 13(1):123-5. PubMed ID: 8673091
[TBL] [Abstract][Full Text] [Related]
28. The D13S171 marker, misannotated to BRCA2, links the AS3 gene to various cancers.
Geck P; Sonnenschein C; Soto AM
Am J Hum Genet; 2001 Aug; 69(2):461-3. PubMed ID: 11452363
[No Abstract] [Full Text] [Related]
29. The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators.
Gayther SA; de Foy KA; Harrington P; Pharoah P; Dunsmuir WD; Edwards SM; Gillett C; Ardern-Jones A; Dearnaley DP; Easton DF; Ford D; Shearer RJ; Kirby RS; Dowe AL; Kelly J; Stratton MR; Ponder BA; Barnes D; Eeles RA
Cancer Res; 2000 Aug; 60(16):4513-8. PubMed ID: 10969800
[TBL] [Abstract][Full Text] [Related]
30. CGH analysis of familial non-BRCA1/BRCA2 breast tumors and mutation screening of a candidate locus on chromosome 17q11.2-12.
Maguire P; Holmberg K; Kost-Alimova M; Imreh S; Skoog L; Lindblom A
Int J Mol Med; 2005 Jul; 16(1):135-41. PubMed ID: 15942690
[TBL] [Abstract][Full Text] [Related]
31. Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study.
Antoniou AC; Pharoah PD; McMullan G; Day NE; Ponder BA; Easton D
Genet Epidemiol; 2001 Jul; 21(1):1-18. PubMed ID: 11443730
[TBL] [Abstract][Full Text] [Related]
32. A population study of mutations and LOH at breast cancer gene loci in tumours from sister pairs: two recurrent mutations seem to account for all BRCA1/BRCA2 linked breast cancer in Iceland.
Arason A; Jonasdottir A; Barkardottir RB; Bergthorsson JT; Teare MD; Easton DF; Egilsson V
J Med Genet; 1998 Jun; 35(6):446-9. PubMed ID: 9643283
[TBL] [Abstract][Full Text] [Related]
33. Frequent loss of heterozygosity at chromosome 13q12-13 with BRCA2 markers in sporadic male breast cancer.
Prechtel D; Werenskiold AK; Prechtel K; Keller G; Höfler H
Diagn Mol Pathol; 1998 Feb; 7(1):57-62. PubMed ID: 9646036
[TBL] [Abstract][Full Text] [Related]
34. [Risk assessment for familial occurrence of breast cancer].
Chang-Claude J; Becher H; Hamann U; Schroeder-Kurth T
Zentralbl Gynakol; 1995; 117(8):423-34. PubMed ID: 7571905
[TBL] [Abstract][Full Text] [Related]
35. Linkage analysis of BRCA1 in Japanese breast cancer families.
Inoue R; Fukutomi T; Ushijima T; Matsumoto Y; Sugimura T; Nagao M
Jpn J Cancer Res; 1994 Dec; 85(12):1233-9. PubMed ID: 7852187
[TBL] [Abstract][Full Text] [Related]
36. Loss of heterozygosity in BRCA1 and BRCA2 markers and high-grade malignancy in breast cancer.
Silva JM; Gonzalez R; Provencio M; Dominguez G; Garcia JM; Gallego I; Palacios J; España P; Bonilla F
Breast Cancer Res Treat; 1999 Jan; 53(1):9-17. PubMed ID: 10206068
[TBL] [Abstract][Full Text] [Related]
37. Absence of evidence for a familial breast cancer susceptibility gene at chromosome 8p12-p22.
Rahman N; Teare MD; Seal S; Renard H; Mangion J; Cour C; Thompson D; Shugart Y; Eccles D; Devilee P; Meijers H; Nathanson KL; Neuhausen SL; Weber B; Chang-Claude J; Easton DF; Goldgar D; Stratton MR
Oncogene; 2000 Aug; 19(36):4170-3. PubMed ID: 10962578
[TBL] [Abstract][Full Text] [Related]
38. BRCA1 and BRCA2 genes: role in hereditary breast and ovarian cancer in Italy.
Santarosa M; Dolcetti R; Magri MD; Crivellari D; Tibiletti MG; Gallo A; Tumolo S; Della Puppa L; Furlan D; Boiocchi M; Viel A
Int J Cancer; 1999 Sep; 83(1):5-9. PubMed ID: 10449599
[TBL] [Abstract][Full Text] [Related]
39. High throughput fluorescence-based conformation-sensitive gel electrophoresis (F-CSGE) identifies six unique BRCA2 mutations and an overall low incidence of BRCA2 mutations in high-risk BRCA1-negative breast cancer families.
Ganguly T; Dhulipala R; Godmilow L; Ganguly A
Hum Genet; 1998 May; 102(5):549-56. PubMed ID: 9654203
[TBL] [Abstract][Full Text] [Related]
40. Frequency of BRCA1 and BRCA2 germline mutations in Japanese breast cancer families.
Ikeda N; Miyoshi Y; Yoneda K; Shiba E; Sekihara Y; Kinoshita M; Noguchi S
Int J Cancer; 2001 Jan; 91(1):83-8. PubMed ID: 11149425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
